Stoke Therapeutics STOK
NASDAQ STOK
$25.04 -0.66 (-2.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Return on Sales [ROS] (2020 - 2026)

Updated

Stoke Therapeutics (STOK) recorded Return on Sales [ROS] of -701.65% in Q2 2026, down 504.07 percentage points from -197.58% a year earlier but up 155.92 percentage points from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

On a TTM basis, Stoke Therapeutics' Return on Sales [ROS] came in at -809.69% as of Jun 30, 2026, down 829.84 percentage points year-over-year; for FY2025, it came in at -11.16%, up 266.15 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a three-year change of +830.08 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -277.31% in FY2024 (+1029.90 pp), -1307.21% in FY2023 (-465.97 pp) and -841.24% in FY2022.
  • Quarterly Return on Sales [ROS] has ranged from -4382.24% in Q4 2025 to 70.15% in Q1 2025 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] has declined for three consecutive quarters, with an average year-over-year change of -398.41 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 995.51 percentage points in Q4 2024, against a drop of 4321.87 percentage points in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -857.57% (Q1 2026), -4382.24% (Q4 2025) and -405.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Stoke Therapeutics 1.56 Bn 393.22 Mn - -701.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -701.65%
Mar 31, 2026 -857.57%
Dec 31, 2025 -4,382.24%
Sep 30, 2025 -405.30%
Jun 30, 2025 -197.58%
Mar 31, 2025 70.15%
Dec 31, 2024 -60.37%
Sep 30, 2024 -613.06%
Jun 30, 2024 -607.37%
Mar 31, 2024 -672.96%
Dec 31, 2023 -1,055.89%
Sep 30, 2023 -823.28%
Jun 30, 2023 -1,340.67%
Mar 31, 2023 -479.23%
Dec 31, 2022 -831.58%
Sep 30, 2022 -934.53%
Jun 30, 2022 -781.12%
Mar 31, 2022 -826.50%
Dec 31, 2021 -68,127.78%
Sep 30, 2021 -51,552.27%
API Access

Stoke Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=STOK&period=max&api_key=YOUR_API_KEY